Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy

NCT03347253 is registered in ClinicalTrials.gov with Amicus Therapeutics as lead sponsor.

NCT NCT03347253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03347253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Lead sponsor
Amicus Therapeutics
Phase
Observational
Overall status
Terminated
Start date
December 8, 2017
Completion date
November 30, 2018
Enrollment
12 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

late-onset pompe disease